| 摘要 |
<p>The invention provides means for treating conditions characterised by inappropriate erythropoiesis. The invention also extends to the treatment of conditions involving inappropriate myeloid leukopoiesis. The invention also extends to pharmaceutical compositions for use in treating such conditions, and to methods of treatment.</p> |
